Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease - 27/09/17
Doi : 10.1016/j.jaci.2016.10.016
Karl Mårild, MD, PhD a 
, Maria Vistnes, MD, PhD a, b, German Tapia, PhD a, Øivind Midttun, PhD c, Per M. Ueland, MD, PhD d, Marte K. Viken, PhD e, Per Magnus, MD, PhD a, Jens P. Berg, MD, PhD f, Lars C. Stene, PhD a, Ketil Størdal, MD, PhD a, g
, Maria Vistnes, MD, PhD a, b, German Tapia, PhD a, Øivind Midttun, PhD c, Per M. Ueland, MD, PhD d, Marte K. Viken, PhD e, Per Magnus, MD, PhD a, Jens P. Berg, MD, PhD f, Lars C. Stene, PhD a, Ketil Størdal, MD, PhD a, g a Norwegian Institute of Public Health, Oslo, Norway
b Department of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway
c Bevital AS, Bergen, Norway
d Department of Clinical Science, University of Bergen and the Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway
e Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway
f Department of Medical Biochemistry, Oslo University Hospital and the Institute of Clinical Medicine, University of Oslo, Oslo, Norway
g Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway
| The Norwegian Mother and Child Cohort Study (MoBa) was supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, National Institutes of Health (NIH)/National Institute of Environmental Health Sciences (NIEHS) (contract no. N01-ES-75558), NIH/National Institute of Neurological Disorders and Stroke (NINDS) (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1). This subproject within MoBa is supported by the Norwegian Research Council (grant no. 221909/F20). The genotyping service for this study was financed by Helse Sør-Øst. K.S. was funded through an unrestricted grant from Oak Foundation, Geneva, Switzerland. The funding sources did not influence the design, conduct, and reporting of the present study. |
|
| Disclosure of potential conflict of interest: O. Midttun is an employee at Bevital, which carried out the analyses on cord blood. P. M. Ueland is a member of the steering board of the nonprofit Foundation to Promote Research into Functional Vitamin B12 Deficiency, which owns Bevital. J. P. Berg receives payment for lectures from MSD and Boehringer Ingelheim. L. C. Stene receives grant support from the Research Council of Norway. K. Størdal receives grant support from Oak Foundation, Geneva. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 139 - N° 5
P. 1696-1698 - mai 2017 Retour au numéro
Article précédent
- Cross-talk between human mast cells and epithelial cells by IgE-mediated periostin production in eosinophilic nasal polyps
- Dae Woo Kim, Marianna Kulka, Ara Jo, Kyoung Mi Eun, Narcy Arizmendi, Brian P. Tancowny, Seung-No Hong, Jung Pyo Lee, Hong Ryul Jin, Richard F. Lockey, Dong-Kyu Kim, Seong H. Cho
- Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
- Scott W. Canna, Charlotte Girard, Louise Malle, Adriana de Jesus, Neil Romberg, Judith Kelsen, Lea F. Surrey, Pierre Russo, Andrew Sleight, Eduardo Schiffrin, Cem Gabay, Raphaela Goldbach-Mansky, Edward M. Behrens
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?